IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

BVF Inc

Q2 2015 Holdings

Filed 2015-08-14 | 30 holdings | $14.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cytokinetics Inc(CYTK)COM NEW23282W605$14.2M2,106,98996.2%
Array Biopharma Inc(ARRYEUR)COM04269X105$66.1K9,169,2760.4%
Chemocentryx Inc(CCXIEUR)COM16383L106$59.8K7,270,0130.4%
Blueprint Medicines Corp(2L9)COM09627Y109$41.9K1,582,4080.3%
Forward Pharma A/SSPONSORED ADR34986J105$38.4K1,008,9810.3%
Concert Pharmaceuticals Inc(CNCEEUR)COM206022105$37.5K2,521,4520.3%
Oncothyreon IncCOM682324108$36.5K9,754,1780.2%
Exelixis IncNOTE 4.250% 8/130161QAC8$34.0K$38,239,0000.2%
Loxo Oncology IncCOM548862101$29.1K1,615,0810.2%
Oncomed Pharmaceuticals IncCOM68234X102$28.5K1,264,7150.2%
Ironwood Pharmaceuticals Inc(IRWD)COM CL A46333X108$26.2K2,171,1080.2%
Vitae Pharmaceuticals IncCOM92847N103$23.1K1,604,6150.2%
Tobira Therapeutics IncCOM88883P101$20.3K1,175,2330.1%
Targacept IncCOM87611R306$18.6K6,655,1280.1%
GTX Inc delCOM40052B108$15.8K10,772,3060.1%
QLT IncCOM746927102$15.4K3,737,4460.1%
Exelixis Inc(EXEL)COM30161Q104$10.4K2,766,1520.1%
Arqule Inc(ARQLUSD)COM04269E107$10.3K6,430,7080.1%
Seattle Genetics IncCOM812578102$9.7K200,0000.1%
Xenon Pharmaceuticals Inc(XENE)COM98420N105$7.8K678,7640.1%
Five Prime Therapeutics Inc(FPRX)COM33830X104$6.0K240,5970.0%
Array Biopharma IncNOTE 3.000% 6/004269XAA3$3.2K$2,500,0000.0%
Catabasis Pharmaceuticals inCOM14875P107$2.7K225,0000.0%
Mast Therapeutics IncCOM576314108$2.5K5,111,2930.0%
Atyr Pharma Inc(LIFEUSD)COM002120103$2.5K134,7250.0%
Oncogenex Pharmaceuticals inCOM68230A106$2.4K1,020,1080.0%
Globeimmune Inc(GBIM)COM37957B100$1.8K678,4000.0%
Biota Pharmaceutials IncCOM090694100$726350,7760.0%
Achaogen IncCOM004449104$643106,7000.0%
Aptose Biosciences IncCOM NEW03835T200$538105,4290.0%